Terms: = Breast cancer AND RANBP2, NUP358, 5903, ENSG00000153201, P49792, TRP1, TRP2 AND Prognosis
4 results:
1. Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in breast cancer.
Stella S; Vitale SR; Massimino M; Motta G; Longhitano C; Lanzafame K; Martorana F; Fazzari C; Vecchio GM; Tirrò E; Inzerilli N; Carciotto R; Manzella L; Caruso M; Vigneri P
Cancer Genomics Proteomics; 2022; 19(4):464-476. PubMed ID: 35732329
[TBL] [Abstract] [Full Text] [Related]
2. TV-circRGPD6 Nanoparticle Suppresses breast cancer Stem Cell-Mediated Metastasis via the miR-26b/YAF2 Axis.
Lin X; Chen W; Wei F; Xie X
Mol Ther; 2021 Jan; 29(1):244-262. PubMed ID: 32950105
[TBL] [Abstract] [Full Text] [Related]
3. MTSS1 suppresses mammary tumor-initiating cells by enhancing RBCK1-mediated p65 ubiquitination.
Cong M; Wang Y; Yang Y; Lian C; Zhuang X; Li X; Zhang P; Liu Y; Tang J; Yang Q; Zhang X; Xiong H; Hu R; Hu G
Nat Cancer; 2020 Feb; 1(2):222-234. PubMed ID: 35122005
[TBL] [Abstract] [Full Text] [Related]
4. Tumor-Specific Regulatory T Cells from the Bone Marrow Orchestrate Antitumor Immunity in breast cancer.
Ge Y; Böhm HH; Rathinasamy A; Xydia M; Hu X; Pincha M; Umansky L; Breyer C; Hillier M; Bonertz A; Sevko A; Domschke C; Schuetz F; Frebel H; Dettling S; Herold-Mende C; Reissfelder C; Weitz J; Umansky V; Beckhove P
Cancer Immunol Res; 2019 Dec; 7(12):1998-2012. PubMed ID: 31672785
[TBL] [Abstract] [Full Text] [Related]
